Empresa Quest Diagnostics Incorporated
Acciones
DGX
US74834L1008
Instalaciones y servicios de atención médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
131,1 USD | +1,70 % | +2,62 % | -4,95 % |
Resumen de negocios
- Pruebas y servicios de diagnóstico (97,3%): pruebas clínicas de rutina, pruebas basadas en genes y servicios avanzados de diagnóstico y anatomía patológica;
- otros (2,7%).
Número de empleados: 44 000
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Diagnostic Information Services
97,0
%
| 9 609 | 97,2 % | 8 976 | 97,0 % | -6,59 % |
All Other
3,0
%
| 274 | 2,8 % | 276 | 3,0 % | +0,73 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 883 | 100,0 % | 9 252 | 100,0 % | -6,38 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
James Davis
CEO | Chief Executive Officer | 61 | 01/04/13 |
Sam Samad
DFI | Director of Finance/CFO | 54 | 11/07/22 |
Kristin Wallace
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 18/02/19 | |
Shawn Bevec
IRC | Investor Relations Contact | - | - |
Sean Mersten
SEC | Corporate Secretary | - | - |
Mark Delaney
PRN | Corporate Officer/Principal | - | 01/03/22 |
Michael Deppe
AUD | Comptroller/Controller/Auditor | 59 | 01/01/98 |
Alyssa Waxenberg
PRN | Corporate Officer/Principal | 53 | 01/01/21 |
Doug Lang
PRN | Corporate Officer/Principal | - | 01/04/13 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Denise Morrison
BRD | Director/Board Member | 70 | 18/02/19 |
Timothy Ring
BRD | Director/Board Member | 67 | 07/12/11 |
Gail Wilensky
BRD | Director/Board Member | 80 | 01/01/97 |
Gary M. Pfeiffer
BRD | Director/Board Member | 74 | 01/12/04 |
Timothy Main
BRD | Director/Board Member | 66 | 13/01/14 |
Vicky Gregg
BRD | Director/Board Member | 69 | 22/07/14 |
Tracey Doi
BRD | Director/Board Member | 63 | 17/08/21 |
Wright Lassiter
BRD | Director/Board Member | 60 | 12/03/20 |
James Davis
CEO | Chief Executive Officer | 61 | 01/04/13 |
Luis A. Diaz
BRD | Director/Board Member | 53 | 17/05/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 161 707 293 | 109 751 133 ( 67,87 %) | 51 000 000 ( 31,54 %) | 67,87 % |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Blueprint Genetics Oy
Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. |
Biotechnology
|
Quest Diagnostics India Pvt Ltd.
Quest Diagnostics India Pvt Ltd. Medical/Nursing ServicesHealth Services Quest Diagnostics India Pvt Ltd. provides pathology and clinical laboratory testing services. It offers employee life cycle approach, pre-employment screening, drug testing solutions, occupational exposure screening and monitoring blueprint for wellness driving healthy behavior & outcomes. The company is headquartered in Gurgaon, India. |
Medical/Nursing Services
|
Quest Diagnostics HTAS India Pvt Ltd.
|
Sector
Ventas por actividad
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-4,95 % | 14,51 mil M | |
+0,60 % | 99,96 mil M | |
+22,54 % | 87,73 mil M | |
+10,63 % | 29,33 mil M | |
-4,72 % | 18,21 mil M | |
+19,29 % | 12,22 mil M | |
+30,63 % | 12 mil M | |
-0,92 % | 11,94 mil M | |
-32,28 % | 11,56 mil M | |
-10,67 % | 11,63 mil M |
- Bolsa
- Acciones
- Acción Quest Diagnostics Incorporated - Nyse
- Empresa Quest Diagnostics Incorporated